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CardioprotectionMitochondrial dysfunction contributes to cardiac ischemia–reperfusion (IR) injury but volatile anesthetics (VA)
may alter mitochondrial function to trigger cardioprotection. We hypothesized that the VA isoﬂurane (ISO)
mediates cardioprotection in part by altering the function of several respiratory and transport proteins involved
in oxidative phosphorylation (OxPhos). To test this we used ﬂuorescence spectrophotometry to measure the
effects of ISO (0, 0.5, 1, 2 mM) on the time-course of interlinked mitochondrial bioenergetic variables during
states 2, 3 and 4 respiration in the presence of either complex I substrate K+-pyruvate/malate (PM) or complex
II substrate K+-succinate (SUC) at physiological levels of extra-matrix free Ca2+ (~200 nM) and Na+ (10 mM).
To mimic ISO effects on mitochondrial functions and to clearly delineate the possible ISO targets, the observed
actions of ISO were interpreted by comparing effects of ISO to those elicited by low concentrations of inhibitors
that act at each respiratory complex, e.g. rotenone (ROT) at complex I or antimycin A (AA) at complex III. Our con-
clusions are based primarily on the similar responses of ISO and titrated concentrations of ETC. inhibitors during
state 3. We found that with the substrate PM, ISO and ROT similarly decreased the magnitude of state 3 NADH
oxidation and increased the duration of state 3 NADH oxidation, ΔΨm depolarization, and respiration in a
concentration-dependent manner, whereas with substrate SUC, ISO and ROT decreased the duration of state 3
NADH oxidation, ΔΨm depolarization and respiration. Unlike AA, ISO reduced the magnitude of state 3 NADH
oxidation with PM or SUC as substrate. With substrate SUC, after complete block of complex I with ROT, ISO
and AA similarly increased the duration of state 3 ΔΨm depolarization and respiration. This study provides a
mechanistic understanding in how ISO alters mitochondrial function in a way that may lead to cardioprotection.
© 2013 Published by Elsevier B.V.1. Introduction
Mitochondria are primarymediators of cardiac ischemia–reperfusion
(IR) injury [1–4]; they are also important targets for volatile anesthetic
(VA)-induced cardioprotection against IR injury [3,5–12]. Cardio-
protection by a VA can be instituted either before the onset of ischemia
(anesthetic pre-conditioning: APC) or at the onset of reperfusion
(anesthetic post-conditioning: APOC) [13,14]. Regardless of the cardio-
protective strategy, VAs exert effects on mitochondrial function.
Mitochondrial failure consequent to bioenergetic dysfunction leads
to cell damage during IR but speciﬁc components of the mitochondrial
bioenergetic mechanisms may be targets for the actions of VAs that
underlie APC or APOC against IR injury. Volatile anesthetics, including
isoﬂurane (ISO) are known to mediate cardioprotection against IR
injury, in part, by attenuating function of the electron transport chain
(ETC) protein complex I (NADH oxidoreductase) and by triggering mildvier B.V.ROS production, a critical mediator for cellular protection [15–18]. The
mechanisms of ISO and other VAs to alter mitochondrial function and
confer cardioprotection via their actions on ETC complexes and other
mitochondrial transport proteins, however, are not well understood.
It may seem incongruous at ﬁrst that IR-induced injury ultimately
leads to dysfunction of mitochondrial respiration but, on the other
hand, attenuation of mitochondrial respiration might minimize mito-
chondrial injury and reduce cell death during cardiac IR injury [19,20].
Thus, an understanding of ISO-induced actions on selective mitochon-
drial proteins, including the ETC complexes and transport proteins
that are crucial for oxidative phosphorylation (OxPhos), is essential in
elucidating the mechanisms of ISO-induced cardioprotection against
IR injury.
In our recent study in isolated mitochondria [8] in which we dem-
onstrated that ISO attenuates Ca2+ extrusion by the mitochondrial
Na+/Ca2+ exchanger, we also found that ISO caused a concentration-
dependent decrease in the rate of state 3 NADH oxidation and ADP
phosphorylation with the complex I substrate pyruvate/malate (PM).
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supported by later ﬁndings [23,24]. Our initial observed effects of ISO
[8] to increase the duration of state 3 NADH oxidation and ΔΨm depo-
larization also supported complex I as a site of action, but this could
alternatively have been due to inhibition of other ETC. complexes down-
stream of complex I, e.g., complexes III (ubiquinol cytochrome c oxido-
reductase), IV (cytochrome c oxidase) and V (F1F0 ATP synthase), or
complex II (succinate dehydrogenase) and transport proteins (e.g. ade-
nine nucleotide transporter, ANT); alternatively, as has been reported,
ISO might act as an uncoupling agent by promoting a proton leak [25]
that could lead to mild ΔΨm depolarization.
Because our understanding of themechanisms of ISO-targetedmito-
chondrial interventions is notwell deﬁned, we compared the ISO effects
to those elicited by low concentrations of known site-speciﬁc inhibitors
of mitochondrial proteins. That is, we explored the potential mitochon-
drial targets of ISO by comparing its concentration-dependent effects
with the concentration-dependent effects of known inhibitors of ETC.
complexes and mitochondrial transport proteins to identify, and also
rule out, possible ISO targets. In thiswaywe hoped to better understand
how VA-induced modiﬁcation of mitochondrial bioenergetics can
contribute to cardioprotection. To carry out our aims we used isolated
cardiac mitochondria energized with substrates K+-pyruvate/malate
(PM), K+-succinate (SUC) or SUC + Rotenone (ROT, 1 μM). Low
concentrations of ROT antimycin A (AA), oligomycin (OMN), and
atractyloside (ATR) were used to stepwise attenuate complexes I, III, V
and ANT function, respectively; low concentrations of malonate (MAL)
and potassium cyanide (KCN)were used in some experiments to atten-
uate functions of complexes II and IV, respectively.
2. Materials and methods
2.1. Mitochondrial isolation
Mitochondria were freshly isolated from hearts of Wistar rats
(300–350 g) using protocols approved by the Medical College of
Wisconsin Institutional Animal Care and Use Committee (IACUC) as
described previously [8]. Brieﬂy, rats were anesthetized with an intra-
peritoneal injection of inactin (150 mg/kg), and the ventricles were ex-
cised and placed in an ice-cold isolation buffer that contained (in mM):
200mannitol, 50 sucrose, 5 KH2PO4, 5MOPS, 1 EGTA and 0.1% BSA,with
pH adjusted to 7.15 with KOH. The ventricles were minced in the pres-
ence of 5 U/ml protease (Bacillus licheniformis, Sigma) followed by dif-
ferential centrifugation. All isolation procedures were carried out at
4 °C. Mitochondrial protein content was determined by the Bradford
method [26]. The ﬁnal mitochondrial pellet was resuspended in isola-
tion buffer and kept on ice. All chemicals were procured from Sigma
(St. Louis, MO, USA), unless stated otherwise.
2.2. Measure of mitochondrial redox state (NADH)
NADH autoﬂuorescencewasmeasured in themitochondrial suspen-
sion during states 2, 3 and 4 respiration using ﬂuorescence spectropho-
tometry at excitation wavelength 350 nm and emission wavelengths
395 nm and 456 nm (Photon Technology International, Birmingham,
NJ), as we have described before [8,27–30]. At the end of each experi-
ment (390 s), maximal (fully reduced) NADH (high NADH/NAD+)
was determined with 1 μM ROT, which completely blocks electron
transport via FeS centers in complex I at the ubiquinone (Q) binding
site so that proton pumping from NADH cannot occur; minimal (fully
oxidized) NADH (low NADH/NAD+) was determined with 20 μM
triﬂuorocarbonylcyanidephenylhydrazone (FCCP), which induces maxi-
mal proton leak, and causes an increase in proton pumping and electron
transfer between ETC complexes. The ratio of emission ﬂuorescence
(456/395) was normalized between the fully oxidized (with FCCP)
state to the fully reduced (with ROT) state to represent % NADH as the
total pool of NADH + NAD+.2.3. Measure of mitochondrial membrane potential (ΔΨm)
ΔΨm was measured in the mitochondrial suspension during
states 2, 3 and 4 respiration by ﬂuorescence spectrophotometry
using the ﬂuorescent dye tetramethyl-rhodamine methyl ester
(1 μM TMRM; Molecular Probes, Eugene, OR) at excitation wave-
lengths 546 nm and 573 nm and emission wavelength 590 nm [31],
as we have described [29]. TMRM is a ratiometric, membrane potential
sensitive, cationic ﬂuorophore that equilibrates across the inner mito-
chondrial membrane (IMM) based on its electrochemical potential.
ΔΨm measurements followed the same time-line protocol as NADH
measurements except that the respiratory uncoupler carbonyl cyanide
m-chlorophenylhydrazone (4 μM CCCP) was used to fully depolarize
ΔΨm. The ratio of excitation wavelengths (546/573) at any time point
was plotted as a percent of maximum ﬂuorescence (100%) obtained
by maximal depolarization with CCCP.
2.4. Measure of mitochondrial O2 consumption
Mitochondrial O2 consumption rate (respiration) was measured
using a Clark-type O2 electrode (System S 200A; Strathkelvin Instru-
ments, Glasgow, UK) as we have described before [8,30,32,33]. Func-
tional integrity of mitochondria was determined by the respiratory
control index (RCI), deﬁned here as the ratio of state 3 (after added
ADP) to state 4 respiration (after complete phosphorylation of the
added ADP). Only mitochondrial preparations with RCIs ≥ 6, measured
with PM, were used to conduct further experiments.
2.5. Protocol
Measures of the three bioenergetic variables (NADH, ΔΨm, and res-
piration)were conductedwithmitochondria (0.5 mg/ml) suspended in
respiration buffer that contained (in mM): 130 KCl, 10 NaCl, 0.5 CaCl2, 5
K2HPO4, 20 MOPS, 1 EGTA and 0.1% BSA at pH 7.15 adjusted with KOH,
at room temperature (25 °C). NADH, ΔΨm, and respiration were moni-
tored under complex I-linked substrate (10 mM PM) or complex II-
linked substrate (10 mM SUC) during respiratory states 2 (before
adding ADP), 3 (during phosphorylation of 250 μM ADP), and 4 (after
complete phosphorylation of the ADP). Along with drug free controls
(0.1% DMSO), either of three concentrations of ISO (0.5, 1, 2 mM) or
several titrated low concentrations of respiratory complex inhibitors
(e.g. 30, 50, 80, 120, 150 nM ROT; 25, 75, 85, 100, 110 nM AA) were
added to the buffer after adding the substrate, followed by ADP. All
drugs were dissolved in DMSO (0.1%). The appropriate volumes of ISO
stock solutions dissolved in DMSO were prepared in tightly sealed
glass vials and speciﬁc volumes from these vials were added to the
experimental buffer (1 ml) to obtain the desired ISO concentrations
(i.e. 0.5, 1 and 2 mM). ISO, 0.5 mM, is equivalent to approximately
1.4% atm at 25 °C with an estimated 1.3 minimum alveolar concentra-
tion (MAC) for rats [23]. To conﬁrm the actual concentrations of ISO in
each mitochondrial suspension, an aliquot of isoﬂurane in solution
from each vial was obtained and measured by gas chromatography at
the beginning (100 s) and end of each experiment (500 s). For added
ISO, the measured values varied within ±10% of their initial prepared
values of 0.5, 1, 1.5 and 2 mM. The time-course protocol consisted
of the following: (1) 0 s, addition of mitochondrial sample into the
respiration buffer and start of recording; (2) 30 s, introduction of the
substrate (PM or SUC or SUC + ROT) (1 μM; high concentration that
completely blocks electron ﬂow from complex I) (state 2); (3) 90 s, ad-
dition of either of DMSO, ISO or other mitochondrial protein inhibitors,
and (4) 150 s, addition of ADP (state 3).
Adding substrate PM or SUC provided for forward electron transfer
from complex I or II through complex IV, respectively, and only reverse
electron transfer from complex II to I with SUC. Substrate SUC with a
complete block of complex I by ROT (1 μM) allowed for forward elec-
tron transfer only from complex II through IV. Sites of inhibition by
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how modulation of ΔΨm and matrix pH are all involved in OxPhos are
shown schematically (Fig. 1).
2.6. Data analysis and statistics
Traces are representative of the mean of three different mitochon-
drial preparations, each with three replicate recordings. Where appro-
priate, data are represented as mean ± SD of three independent
experiments. All data were compiled using Microsoft Excel and ana-
lyzed using one-way ANOVA (analysis of variance) with Turkey's
post-hoc test for signiﬁcance of means. Differences with P b 0.05
(two-tailed) were considered signiﬁcant.
3. Results
3.1. Effect of isoﬂurane vs. respiratory inhibitors on mitochondrial redox
state (NADH)
Time-dependent effects of DMSO (vehicle) and graded concentra-
tions of ISO, complex I (ROT), or complex III (AA) inhibitors in the pres-
ence of the substrate PM or SUC during states 2, 3 and 4 are shown in
Fig. 2A–F. The insets show summaries of their effects on the duration
of ADP-induced state 3 NADH oxidation (S3 time, s). ISO, ROT, and AA
each had no effect on resting state 2 NADH. With the complex I sub-
strate PM, ISO caused pronounced concentration-dependent decreases
in state 3 NADH oxidation with respect to state 2 NADH after adding
ADP: 32 ± 7%, 27 ± 5% and 21 ± 5% at 0.5, 1 and 2 mM ISO, respec-
tively, vs. 42 ± 4%withDMSO. ISO also signiﬁcantly increased the dura-
tion of state 3 NADH oxidation: 50 ± 4 s, 66 ± 6 s and 103 ± 8 s at
0.5, 1 and 2 mM, respectively, vs. 41 ± 5 s for DMSO (Fig. 2A inset).
To deduce if ISO decreased state 3 NADH oxidation by an action on
complex I, the changes in NADH induced by ISO during state 3with sub-
strate PMwere compared to the effects of titrated, low concentrations of
the complex I inhibitor ROT (Fig. 2B). These data showed, similar to ISO,
that ROT attenuated the magnitude of state 3 NADH oxidation in aNADH2 NAD+
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Fig. 1. Schema depicting the mitochondrial electron transport chain (ETC) protein complexes o
(ROT), malonate (MAL), antimycin A (AA), potassium cyanide (KCN), oligomycin (OMN), and
boxylic acid (TCA) cycle in thematrix, while electrons are transferred through the complexes to
(H+) into the intermembrane space (IMS) by complex I, complex III, and complex IV, which g
Depending on the substrate used, K+-pyruvate/malate (PM) or K+-succinate (SUC), isolatedmi
forward or reverse electron transfer (FET or RET) depending on the reduction potential across ea
ETC. components explored in this study.concentration-dependent manner: 35 ± 5%; 25 ± 6%; and 14 ± 4%
at 20, 30 and 50 nM, respectively, vs. 41 ± 4% for DMSO. Also like ISO,
ROT caused a concentration-dependent increase in the duration of
state 3 NADH oxidation (Fig. 2B inset).
To determine if ISO-induced increases in the duration of state 3
NADH oxidation might also result from reduced proton pumping and
electron transfer downstream from complex I, NADH oxidation was
assessed with titrated, low concentrations of the complex III blocker
AA (see Fig. 1). AA caused concentration-dependent increases in the
duration of state 3 NADH oxidation (Fig. 2C; inset), but unlike ISO and
ROT, it did not decrease the magnitude of state 3 NADH oxidation.
These data indicated thatwith PMas substrate, ISOdecreased the extent
and increased the duration of state 3 NADH oxidation similar to that
of ROT, while it only increased the duration of state 3 NADH oxidation
similar to that of AA. This indicated that both complexes I and III
might be functional targets for ISO to retard restoration of the redox
state (Fig. 7A).
To test if the ISO-induced changes in the extent and duration of state
3 NADH oxidation could also result from reduced inward translocation
of ADP in exchange for ATP extrusion (Fig. 1), NADH oxidation was
measured with low concentrations (0.25 to 1 μM) of the ANT inhibitor,
ATR. But, unlike ISO, ATR caused concentration-dependent decreases
in both the extent and duration of state 3 NADH oxidation (data not
shown); together these ﬁndings suggested that there was reduced
ADP entry and availability during state 3 to oxidize NADH. The complex
IV blocker KCN at low titrated concentrations (up to 1 μM) did not
exhibit effects similar to ISO on any of the mitochondrial bioenergetic
variables with any substrate tested (data not shown).
We tested further if the prolonged effects of ISO on the duration
of NADH oxidation with the substrate PM during state 3 were different
from those elicited by the complex II substrate SUC (Fig. 2D) and
how these responses compared with the effects of 30–150 nM ROT
(Fig. 2E) or 100 and125 nMAA (Fig. 2F).With the substrate SUC, adding
ADP prolonged the duration of NADHoxidation substantially more than
with the substrate PM (Fig. 2D vs. A). ISO tended to only slightly reduce
the magnitude of oxidation but to markedly decrease the duration ofe-
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Fig. 2. Normalized mitochondrial redox state (NADH/NADH + NAD+) during states 2, 3 and 4 respiration with different substrates and either ISO or a blocker of ETC complexes. State 2
was induced with 10 mM PM (A–C) or SUC (D–F) and state 3 with 250 μM ADP; state 4 is after phosphorylation of all ADP to ATP. ISO, ROT, or AAwas added after PM or SUC and before
ADP. ADP induced a transient decrease in the reduced state of NADH. The insets summarize effects of ISO compared to ROT and AA on duration of ADP-induced state 3 NADH oxidation
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excess FCCP or ROT, respectively. Data represent mean ± SD of 3 replicates.
357B. Agarwal et al. / Biochimica et Biophysica Acta 1837 (2014) 354–365NADH oxidation (Fig. 2D inset). Because ROT attenuates both forward
and reverse electron transfer through complex I, enhancing attenuation
of proton pumping and electron transfer by ROT or ISO leads to less
oxidation of NADH during state 3. ROT had a greater effect than ISO on
both the extent and duration of NADH oxidation (Fig. 2E vs. D) suggest-
ing that ISO may attenuate complex I function somewhat differently
than ROT, which blocks electron transfer via a FeS centers at the Qbinding site in complex I. In contrast to the effects of ISO and
ROT on attenuating state 3-induced oxidation of NADH with the
substrate SUC, AA did not change the extent or duration of NADH
oxidation (Fig. 2F) when compared to DMSO. Thus, these results
suggested that ISO-induced effects on NADH redox state were me-
diated by attenuating complex I electron transfer, which in turn
impeded proton pumping by NADH.
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membrane potential (ΔΨm)
Time-dependent effects of DMSO (vehicle) and graded concentra-
tions of ISO, complex I (ROT), or complex III (AA) inhibitors on ΔΨm
in the presence of PM or SUC during respiratory states 2, 3 and 4 are
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compared to DMSO, adding ADP after ISO, ROT, or AA caused a delay
in state 3 ΔΨm repolarization (Fig. 3A,B,C).
Like ISO, ROT had similar effects on the duration of state 3 ΔΨm
depolarization (Fig. 3A,B insets) and NADH oxidation (Fig. 2A,B insets)
and on the increase in the magnitude of state 3 ΔΨm depolarization;
thiswas likely due to attenuation of complex I electron transfer and pro-
ton pumping during state 3. Like ISO (Fig. 3A inset), ROT and AA caused
concentration-dependent increases in the duration of state 3 ΔΨm de-
polarization (Fig. 3B,C insets). The observed ISO-induced increases in
the extent and the duration of state 3 ΔΨm depolarization (Fig. 3A)
were consistent with the observed ISO-induced decrease in the extent
and increase in the duration of state 3 NADH oxidation (Fig. 2A).
Unlike ISO with the substrate PM, and as observed with NADH,
ATR (0.5–1 μM) caused a concentration-dependent attenuation of the
ADP-induced decrease in ΔΨm, likely due to reduced ADP translocation
through ANT (data not shown); Thus, themarked differences in ISO and
ATR responses suggested again that the effects of ISOwere notmediated
via ANT.
Similar to the NADH measurements (Fig. 2), we also compared
the effects of ISO, ROT, and AA (Fig. 3D,E,F), respectively, on
changing the extent and duration ofΔΨmdepolarization in the presence
of the complex II substrate SUC during states 2, 3 and 4. ISO, ROT and AA
had no effects on resting state 2 ΔΨm. Adding ADP in the ISO and ROT
groups caused small decreases in themagnitude of ΔΨm depolarization
(Fig. 3D,E) and signiﬁcant concentration-dependent decreases in the
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concentration-dependent effects of ISO vs. ROT and AA (Fig. 3A–C) on
the duration of the transient ΔΨm depolarization during state 3 dura-
tion (Fig. 3A inset) with NADH-linked substrate PM supports the notion
that complexes I and III are targets for attenuated mitochondrial func-
tion by ISO. In contrast, giving AA in the presence of SUC did not
mimic the effects of ISO on the duration of state 3 ΔΨm depolarization
(Fig. 3D vs. 3 F).
Because the state 3 effects on the duration ofΔΨm depolarization for
ISO were similar to those of ROT, but somewhat dissimilar to AA in the
presence of substrate SUC (Fig. 3D vs. E and F), we conducted additional
experiments in which complex I was completely blocked by 1 μM ROT
before adding SUC; this was followed by addition of ISO or AA. Under
these conditions both ISO and AA caused increases in the duration
of ADP-induced ΔΨm depolarization, which re-afﬁrmed that ISO has
inhibitory effects on complex III (Fig. 4A,B). In this scenario it was likely
that ISO, like AA, exerted similar effects to inhibit complex III when SUC
was the substrate with complete inhibition of reverse electron transfer
(RET) before adding SUC. When ISO (or AA) was added, the duration
of ΔΨm depolarization increased because of slowed forward electron
transfer (FET) to complex IV from complex III (Figs. 1, 7C). This slowing
led to the increases in the duration of state 3 ΔΨm depolarization.
However, it remained possible that ISO could also slow electron
transport at complex II since thiswas another site of electron generation
with SUC as the substrate. With complex I completely blocked by ROT,
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maximal state 3 ΔΨm depolarization (Fig. 4C) and state 3 duration
(Fig. 4C inset). Because this is unlike the response of ISO to the increased
state 3 duration, we concluded that ISO has no demonstrable effects on
complex II.0
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(150 nM–3 μM), there was a concentration dependent decrease in
ADP-induced state 3 ΔΨm depolarization (Fig. 4D); but there was no
signiﬁcant change in the duration of ADP phosphorylation because of
lesser exchange of ADP for ATP compared to the DMSO (vehicle)
group. The effects of ATR on OxPhos show that ATR incrementally
inhibited ANT. The variable responses between ISO and ATR suggested
and supported our previous observation that ISO does not have an ap-
preciable effect on ANT activity.
3.3. Effect of isoﬂurane vs. respiratory inhibitors on mitochondrial O2
consumption
Time-dependent effects of DMSO (vehicle) and graded concentra-
tions of ISO, complex I (ROT), or complex III (AA) inhibitors on O2 con-
sumption rate in the presence of PM or SUC during states 2, 3 and 4
respirations are shown in Fig. 5A–F. The insets show summaries of treat-
ment effects on state 3 and state 4. With the complex I substrate PM,
ISO signiﬁcantly slowed state 3 respiration rate in a concentration-
dependent manner: 183 ± 7 (0.5 mM ISO), 106 ± 8 (1 mM ISO), and
91 ± 8 (2 mM ISO) vs. 220 ± 6 (DMSO) nmol·min−1·mg−1(Fig. 5A
inset), with small decreases in state 4 respiration: 59 ± 7 (0.5 mM
ISO), 44 ± 8 (1 mM ISO), and 32 ± 7 (2 mM ISO) vs. 32 ± 6 (DMSO)
nmol·min−1·mg−1 (Fig. 5A inset). ISO also prolonged the duration
of state 3 respiration: 23 ± 4 s, 40 ± 6 s and 49 ± 5 s at 0.5, 1 and
2 mM ISO, respectively, vs. 21 ± 6 s with DMSO. Like ISO, low concen-
trations of ROT also caused concentration-dependent decreases in res-
piration and increases in state 3 duration (Fig. 5B). These results are
consistent with the effects of ISO and ROT to decrease the magnitude
and to increase the duration of NADH oxidation (Fig. 2A,B). Unlike
ISO and ROT, AA (in high concentrations)with the substrate PM, caused
a slight but signiﬁcant decrease in respiration rate (Fig. 5C inset) and
duration of state 3 (Fig. 5C), which are consistent with the small
increases in the duration of state 3 NADH oxidation and ΔΨm depolari-
zation (Figs. 2C and 3C).
ISO did not signiﬁcantly decrease state 3 respiration rate in a
concentration-dependent manner with complex II substrate SUC
(Fig. 5D). Unlike with the substrate PM, with substrate SUC, ISO
decreased state 3 duration: 63 ± 7 s, 60 ± 6 s and 59 ± 5 s at 0.5, 1
and 2 mM ISO, respectively, vs.73 ± 4 s with DMSO. The effects of
ISO with substrate SUC (Fig. 5D) were compared with those of ROT
(Fig. 5E) and AA (Fig. 5F). In a concentration-dependent manner, ISO
decreased state 4 respiration rate, possibly by inhibiting complex I
with attenuation of RET from the reducedQ pool to complex I. The effect0
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Fig. 6.Mitochondrial O2 concentration (nmol·min−1) during states 2, 3 and 4 respiration with
before succinate to maximally block complex I and RET. The insets summarize effects of adde
Note similarities and differences of responses to each drug. Data represent mean ± SD of 3 repof ISO to decrease state 4 respiration with substrate SUC was again
shown to result from attenuated complex I activity because these
results were consistent with the effect of ROT to decrease state 4 respi-
ration (Fig. 2 D,E). Unlike ISO, adding AA (at higher concentrations)
caused an increase in state 3 respiration compared to DMSO (Fig. 5D
vs. F). The effects of ISO, ROT, and AA on concentration-dependent
changes in the duration of state 3 respiration showed that responses
to ISO closely matched those of ROT with SUC as the substrate
(Fig. 5D,E,F).
The effects of ISO and AA on respiration rates with SUC as the
substrate after complete block of complex I with high ROT (1 μM)
were compared (Fig. 6A,B) aswas done forΔΨm (Fig. 4A,B). ISO slightly,
but signiﬁcantly, increased state 3 respiration: 120 ± 5 (DMSO),
128 ± 7 (0.5 ISO), 139 ± 6 (1 mM ISO) and 136 ± 7 (2 mM ISO)
nmol·min−1·mg−1; ISO induced a small but signiﬁcant increase in
state 4 respiration. In contrast, AA induced more pronounced increases
in state 3 respiration: 120 ± 8 (DMSO), 228 ± 8 (10 nM AA), 210 ± 8
(20 nM AA) and 213 ± 1 (25 nM AA) nmol·min−1·mg−1. AA also
increased state 4 respiration: 93 ± 8 (DMSO) 133 ± 6 (10 nM AA),
127 ± 7 (20 nM AA), 115 ± 7 (25 nM AA) nmol·min−1·mg−1 that
could be attributed to electron leak at the inhibited complex III site.
Thus, when complex I was completely blocked, electron transfer from
complex II to complex IV became attenuated as complex III was step-
wise blocked. With blocked proton pumping at complex I and reduced
proton pumping at complexes III and IV, this tended to reduce the
redox state and ΔΨm (Fig. 4A,B), thus stimulating respiration. During
state 3 respiration with proton inﬂux at complex V, respiration became
even faster until ΔΨm was restored.
4. Discussion
The mitochondrion has emerged as a key component in VA-
mediated cardioprotection against IR injury. VAs (e.g. ISO) could pro-
vide cellular protection against IR injury, in part, by direct effects on
mitochondrial ETC. complexes or on other proteins (ANT) involved in
OxPhos that result in attenuated mitochondrial damage. Prior reports
indicate that VAs likely have depressant effects on mitochondrial func-
tion [34–36]. However, the speciﬁc targets and mechanisms of VA
action on mitochondrial respiration and phosphorylation remain to be
understood.
The aim of this study was to identify and characterize potential tar-
gets of ISO in isolated cardiac mitochondria by monitoring changes in
bioenergetic variables (NADH, ΔΨm, and respiration) during states 2,
3 and 4 respiration. To do so we used different substrates (PM, SUC,0
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licates.
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with ETC complex inhibitors (ROT, AA, MAL, KCN and OMN) or the
ANT inhibitor ATR, each given in ascending submaximal concentrations.
Overall, we found that ISO caused concentration-dependent differential
modulation of mitochondrial NADH,ΔΨm, and respiration under differ-
ent substrate conditions. Based on the responses and comparisons of
ISO and classical ETC inhibitors (Fig. 1) on different states of respiration,
we concluded that complex I and complex III are speciﬁc respiratory
protein targets of ISO by comparing the bioenergetic effects of ISO
with those of classical inhibitors. In contrast, using the same approach,
our data suggests that ISO does not signiﬁcantly impair the function of
complexes II, IV, V or ANT. The differential modulation of mitochondrial
function under different substrate conditionswith ISO provides insights
into the more or less selective interaction of ISO with mitochondrial
proteins. These targets could have signiﬁcant implications for themech-
anism of VA-induced protection against cardiac oxidative stress and
could also account, in part, for themild negative inotropic effect of VA's.4.1. Isoﬂurane-induced differential modulation of bioenergetics with
substrate PM
Transient NADH oxidation to NAD+ during ADP-stimulated respira-
tion is due to a transient decrease in NADH secondary to enhanced pro-
ton pumping and electron transfer to replace proton inﬂux via complex
V (see Fig. 1). ISO and ROT exhibited very similar effects to attenuate the
magnitude and increase the duration of state 3 NADHoxidation (Fig. 2A,
B and insets). These effects are likely due to restricted proton pumping
by complex I so that proton entry into complex V after adding ADP is
slowed and prolonged. The ISO-induced concentration-dependent
decreases in NADH oxidation and increases in state 3 NADH duration
suggested that ISO attenuates the increases in electron transfer and pro-
ton pumping induced by proton inﬂux driven ADP phosphorylation
(Fig. 7A); these data were consistent with our previous observation of
partial inhibition of complex I by ISO [8]. The low concentrations of
ROT (20–80 nM), to mimic the effects of ISO, are believed to partially
block electron transfer (and so proton pumping) between the NADH
binding site via FeS centers and the Q binding site in complex I.
Althoughwededuced that ISO attenuates complex I function in a similar
manner, the concentrations of ISO required to produce the same effect
on complex I are about 103 higher; this may indicate that the potency
of ISO for an effect on the Q binding site of complex I is very low or
that the molecular mechanism of inhibition on complex I is dissimilar
(less speciﬁc) from that of ROT. For example, although ROT, like ISO,
increased the duration of state 3 ΔΨm depolarization (Fig. 3A,B), ISO
did not change the extent/magnitude of depolarization, whereas ROT
increased it substantially. These differential effects on the extent of
maximal state 3 ΔΨm depolarization and NADH oxidation by ISO and
ROT appears to imply that ISO attenuated complex I function somewhat
differently than ROT. For example, the ISO-induced increase in the dura-
tion of ADP phosphorylation is most likely due to attenuation of proton
pumping downstream of complex I to better match the slower rates
of electron transfer and ADP phosphorylation due to inhibition of the
complex. This implies that ISO may have effects other than on complex
I only.
ISO, like the complex III Qi site inhibitor AA [37–39], increased the
duration of state 3 ΔΨm (Fig. 3A,C) implying that ISO may attenuate
complex III in addition to complex I. On the other hand, ISO increased
the duration of state 3 ΔΨmmore than AA (Fig. 3A,C). AA and ROT sim-
ilarly prolonged the duration of state 3 ΔΨm (Fig. 3B,C) but did not ex-
actly match the effect of ISO (Fig. 3A), which again implicates complex
III as another site of ISO action. The ISO and AA-induced increases in
duration of ADP phosphorylation most likely result from attenuated
proton pumping at complexes III and IV downstream of complex I due
to attenuated rates of electron transfer. Note that because ISO appears
to simultaneously inhibit complexes I and III, the greater state 3durations of NADH oxidation and ΔΨm depolarization by ISO vs. AA
may be due to ISO additionally inhibiting complex I.
The net effect of proton inﬂux at complex V with addition of ADP
(Fig. 1) is to temporarily depolarize the IMM and consume NADH as
respiration is enhanced to restore theΔΨm and NADH (reducing equiv-
alents). ISO, ROT, and AA each slowed state 3 respiration (Fig. 5A,B,C),
presumably because of reduced electron transfer to complex IV asso-
ciated with decreased proton pumping at complexes I and III. These re-
sults extend previous ﬁndings [8,23] that suggested that the prolonged
duration of state 3 ADP phosphorylation can be attributed to slowed
rates of electron transfer and protonpumping byNADH-linked interme-
diates; this is consistent with the increased duration of state 3 NADH,
ΔΨm, and respiration with the complex I substrate PM.
A decrease in ΔΨm can be caused by any protonophoric effect that
would allowADP-independent inﬂux of protons into thematrix (proton
leak) [40,41], which would increase respiration to restore ΔΨm. We did
not observe any ISO-mediated change in matrix pH with BCECF-AM
incubated mitochondria (data not shown), nor any increase in state 2
respiration to support a proton leak (Fig. 5A). Indeed, during respiratory
states 3 and 4 ISO slowed the rate of respiration, which is not consistent
with a proton leak (Fig. 5A).
A description of FET under these substrate conditions with ISO,
ROT, and AA is depicted in Figs. 1 and 7A. We postulate that the
mild inhibition of complex I with ROT or ISO decreases the NADH-
supported transfer of electrons in the forward direction, i.e. from
complex I to complex III and to complex IV, and this results in
decreased ADP-induced NADH oxidation and increased state 3 dura-
tions of NADH oxidation, ΔΨm and respiration. The mild inhibition
of complex III with AA or ISO decreases transfer of electrons from
complex III to complex IV and this results in an increased duration
of state 3 ΔΨm depolarization, without affecting the magnitude of
NADH oxidation (Figs. 2C and 7A).
4.2. Isoﬂurane-induced differential modulation of bioenergetics with
substrate SUC
The complex II substrate (SUC) causes a reversal of the standard re-
duction potential [25] so that NAD+ is reduced to NADH through RET
and this causes superoxide generation at complex I [40,42]. Under
these conditions ISO and ROT similarly decreased the extent and dura-
tion of ADP-induced state 3 NADH oxidation (Fig. 2D,E) and ΔΨm depo-
larization (Fig. 3D,E). These effects resulted from a decreased rate of
ADPphosphorylation because the rate of state 3 respirationwas actually
slower with ISO and ROT (Fig. 5 D,E). A description of slowed FET under
these substrate conditions with ISO, ROT or AA is depicted in Fig. 7B.
Succinate can generate NADH in complex I through RET, which is sensi-
tive to ΔΨm [43]. We interpret from our ﬁndings that mild inhibition
of complex I with ISO or ROT decreased RET supported generation of
NADH and subsequent oxidation of the available NADH resulted in de-
pressed state 3 respiration. The reduced extent and duration of state 3
by ISO or ROT could be attributed to decreased RET-mediated NADH
generation and impaired oxidation of NADH due to attenuated complex
I function. However, this may not be a major contributing factor since
RET may be less favorable when Ψm is depolarized by the added ADP.
Therefore, an alternative possibility could be that impaired oxidation
of NADH induced by ISO and ROT could lead to a slowing of the TCA
cycle activity, thereby leading to accumulation of oxaloacetate, which
inhibits complex II. Inhibition of complex II would lead to a decrease
in OxPhos capacity with SUC by lowering the ΔΨm to result in a de-
crease in ROS production via oxidation of the ubiquinone pool [44]. A
description of slowed FET under these substrate conditions with ISO,
ROT and AA is depicted in Fig. 7B.
ISO or ROT-induced decreases in the extent and duration of state 3
ΔΨm depolarization (Fig. 3 D,E) by attenuation of complex I at the Q
site would result in decreased NADH oxidation. The net result would
be an increase in reduced NADH and a shorter duration of NADH
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363B. Agarwal et al. / Biochimica et Biophysica Acta 1837 (2014) 354–365oxidation, but decreases in states 3 and 4 respiration (Fig. 5D,E insets).
With the substrate PM, unlike the substrate SUC, the ISO-induced
increase in duration of state 3 NADH oxidation support inhibition of
electron transfer from complex I. However, with the substrate SUC,
the marked decreases in the duration of state 3 ΔΨm depolarization
are more likely attributed either to a decrease in FET from the reduced
Q site of complex I to the Q pool, or to attenuation of SUC-supported
transfer of electrons from complex II by oxaloacetate accumulation.
The accumulation of oxaloacetate could result from the inhibitory effect
of ROT/ISO to reduce oxidation of NADH during state 3 (Fig. 8). This
ISO concentration-dependent effect to decrease state 3 respirationdiminishes the possibility that this is due to blocking complex I electron
transfer from the Q pool to complex I or to attenuation of the redox be-
tween Q and QH; thus this effect favors the possibility of attenuation
in FET along the ETC as depicted in Fig. 8. Moreover, because ISO or
ROT depressed state 3 and state 4 respiration with the substrate SUC
(Fig. 5D,E), this veriﬁes that ISO and ROT mediated attenuation of com-
plex I function did not lead to an increase in respiration as a result of
proton leak at the inhibited complex I. In mitochondria respiring on
SUC, the increases in duration of state 3 ΔΨm depolarization (Fig. 3F)
after treatment with AA could occur by impeding electron transfer
from the SUC-driven reduced Q pool to complex III.
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substrate SUC and block of complex I
ISO attenuates complex III function, as we deduced in part by the
similarity between ISO and AA on increasing the duration of state 3
ΔΨm depolarization with SUC after completely blocking complex I
with 1 μM ROT (Fig. 4A,B). Attenuation of complex III function with
inhibited FET and RET at complex I impedes FET from substrate SUC
and could lead to electron leak andO2− generation [25]. The apparent in-
creases in states 3 and 4 respiration with SUC + ROT (Fig. 6A,B) could
be attributed to increased O2− generation, due to electron leak at com-
plex III with AA, rather than reduction of O2 to H2O [45]. The effects of
mild inhibition of complex III with ISO or AA to decrease transfer of elec-
trons from complex III to complex IV and to increase the duration of
state 3 ΔΨm depolarization is depicted in Fig. 7C.
We additionally explored the possibility that in the presence of
SUC + ROT the ISO-mediated increases in duration of state 3 ΔΨm
depolarization can be alternatively explained by an attenuating effect
of ISO on complex II or ANT function. But unlike ISO, which increased
the duration of ADP phosphorylation, low concentrations of ATR did
not signiﬁcantly change state 3 ΔΨm duration (Fig. 4C,D). This implies
that ISO-mediated increases in state 3 duration are likely attributed
to attenuation of complex III rather than to attenuation of complex II
function or attenuation of transfer of ADP/ATP by ANT. The data obtain-
ed on attenuation of complex IV function by KCN (data not shown),
and it's comparison by ISO, suggests that complex IV is also not a poten-
tial target of ISO.
Because ISO induced small increases in states 2, 3, and 4 respiration
(Fig. 6A) under the substrate SUC + ROT (1 μM),we tested if ISO exhib-
ited characteristics of proton leak (uncoupling) by comparing the effects
of low titrated concentrations of known uncouplers (DNP, FCCP) to
induce mitochondrial ΔΨm depolarization. Compared to ISO, these
uncoupling agents caused a pronounced state 2 depolarization (data
not shown). In addition, matrix acidiﬁcation and ΔΨm depolarizationare hallmarks of proton leak [41,46], but we did not observe any change
in matrix pH measured by BCECF ﬂuorescence (data not shown).4.4. Isoﬂurane-induced effects on complexes I and III: implication for
cardioprotection
Volatile anesthetics protect the myocardium against IR injury,
in part, by modulating mitochondrial respiratory function [47–49] to
mildly disrupt electron transfer and induce small amount of ROS,
which acts as a signaling molecule [11,18,33,35]. In this current study,
we concentrated on identifying the direct effects of ISO on proteins in-
volved in mitochondrial respiration, nucleotide transfer and OxPhos
with the aim to better understand how VAs modulate cardiac function
and confer protection against IR injury.
We proposed that ISO-mediated cardioprotection is initiated by par-
tial inhibition of at least several ETC protein components to cause de-
creased electron transport and induce ROS production, which in turn
initiates cardioprotective pathways. Based on this and prior studies,
we believe it is plausible that ISO protects by attenuating complex I
and complex III activity to cause 1) release of small amounts of ROS at
complex I [50–52] and complex III [53,54] during the period before
ischemia (APC) or after ischemia (APOC), and 2) decrease in O2 con-
sumption by reducing the workload during the period of limited O2
availability during ischemia [55]. These events could limit deleterious
ROS generation during IR and so prevent mitochondria from initiating
apoptotic events leading to cell death. We showed previously that lim-
iting complex I activity during ischemia has the potential to minimize
accumulation of ROS on reperfusion and therefore to protect mitochon-
dria and the cell from oxidative damage [19].
Notably, both complex I and complex III are targets but also sites of
ROS generation [45,56,57]. The cardioprotective effect of ISO against IR
injury could also be triggered by a small rise in ROS by its selective inhi-
bition of ETC activity at complex I [50–52] and complex III [53,54]. Our
study provides useful information on effects of ISO on forward and
backward electron transfer pathways that modulate mitochondrial bio-
energetics in a way that may contribute to cardioprotection.Acknowledgements
This work was supported by the National Institute of Health Grants
P01-GM066730 (ZJB), R01-HL095122 (AKSC and RKD) and R01-
HL089514 (DFS).References
[1] E. Murphy, C. Steenbergen, Mechanisms underlying acute protection from cardiac
ischemia–reperfusion injury, Physiol. Rev. 88 (2008) 581–609.
[2] Q. Chen, A.K. Camara, D.F. Stowe, C.L. Hoppel, E.J. Lesnefsky, Modulation of electron
transport protects cardiac mitochondria and decreases myocardial injury during
ischemia and reperfusion, Am. J. Physiol. Cell Physiol. 292 (2007) C137–C147.
[3] A.K. Camara, M. Bienengraeber, D.F. Stowe, Mitochondrial approaches to protect
against cardiac ischemia and reperfusion injury, Front. Physiol. 2 (2011) 13.
[4] J.S. Armstrong, Mitochondria-directed therapeutics, Antioxid. Redox Signal. 10
(2008) 575–578.
[5] D. Pravdic, Y. Mio, F. Sedlic, P.F. Pratt, D.C. Warltier, Z.J. Bosnjak, M. Bienengraeber,
Isoﬂurane protects cardiomyocytes and mitochondria by immediate and cytosol-
independent action at reperfusion, Br. J. Pharmacol. 160 (2010) 220–232.
[6] A. Stadnicka, J. Marinovic, M. Ljubkovic, M.W. Bienengraeber, Z.J. Bosnjak, Volatile
anesthetic-induced cardiac preconditioning, J. Anesth. 21 (2007) 212–219.
[7] N.R. Van Allen, P.R. Krafft, A.S. Leitzke, R.L. Applegate Ii, J. Tang, J.H. Zhang, The role of
volatile anesthetics in cardioprotection: a systematic review,Med. Gas Res. 2 (2012) 22.
[8] B. Agarwal, A.K. Camara, D.F. Stowe, Z.J. Bosnjak, R.K. Dash, Enhanced charge-
independent mitochondrial free Ca2+ and attenuated ADP-induced NADH oxida-
tion by isoﬂurane: implications for cardioprotection, Biochim. Biophys. Acta 1817
(2012) 453–465.
[9] K. Tanaka, L.M. Ludwig, J.R. Kersten, P.S. Pagel, D.C. Warltier, Mechanisms of
cardioprotection by volatile anesthetics, Anesthesiology 100 (2004) 707–721.
[10] D.F. Stowe, L.G. Kevin, Cardiac preconditioning by volatile anesthetic agents: a deﬁn-
ing role for altered mitochondrial bioenergetics, Antioxid. Redox Signal. 6 (2004)
439–448.
365B. Agarwal et al. / Biochimica et Biophysica Acta 1837 (2014) 354–365[11] M. Zaugg, M.C. Schaub, Signaling and cellular mechanisms in cardiac protection by
ischemic and pharmacological preconditioning, J. Muscle Res. Cell Motil. 24 (2003)
219–249.
[12] M.L. Riess, D.F. Stowe, D.C. Warltier, Cardiac pharmacological preconditioning with
volatile anesthetics: from bench to bedside? Am. J. Physiol. Heart Circ. Physiol. 286
(2004) H1603–H1607.
[13] Z.D. Ge, D. Pravdic, M. Bienengraeber, P.F. Pratt Jr., J.A. Auchampach, G.J. Gross, J.R.
Kersten, D.C.Warltier, Isoﬂurane postconditioning protects against reperfusion injury
by preventing mitochondrial permeability transition by an endothelial nitric oxide
synthase-dependent mechanism, Anesthesiology 112 (2010) 73–85.
[14] P.S. Pagel, Postconditioning by volatile anesthetics: salvaging ischemic myocardium
at reperfusion by activation of prosurvival signaling, J. Cardiothorac. Vasc. Anesth. 22
(2008) 753–765.
[15] R. Bains, M.C. Moe, G.A. Larsen, J. Berg-Johnsen, M.L. Vinje, Volatile anaesthetics
depolarize neural mitochondria by inhibiton of the electron transport chain, Acta
Anaesthesiol. Scand. 50 (2006) 572–579.
[16] M.L. Riess, A.K. Camara, Q. Chen, E. Novalija, S.S. Rhodes, D.F. Stowe, Altered NADH
and improved function by anesthetic and ischemic preconditioning in guinea pig
intact hearts, Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H53–H60.
[17] L.G. Kevin, E. Novalija, M.L. Riess, A.K. Camara, S.S. Rhodes, D.F. Stowe, Sevoﬂurane
exposure generates superoxide but leads to decreased superoxide during ischemia
and reperfusion in isolated hearts, Anesth. Analg. 96 (2003) 949–955(table of
contents).
[18] M.L. Riess, L.G. Kevin, J. McCormick, M.T. Jiang, S.S. Rhodes, D.F. Stowe, Anesthetic
preconditioning: the role of free radicals in sevoﬂurane-induced attenuation of
mitochondrial electron transport in Guinea pig isolated hearts, Anesth. Analg. 100
(2005) 46–53.
[19] M. Aldakkak, D.F. Stowe,Q. Chen, E.J. Lesnefsky, A.K. Camara, Inhibitedmitochondrial
respiration by amobarbital during cardiac ischaemia improves redox state and
reduces matrix Ca2+ overload and ROS release, Cardiovasc. Res. 77 (2008) 406–415.
[20] L.S. Burwell, S.M. Nadtochiy, P.S. Brookes, Cardioprotection by metabolic shut-down
and gradual wake-up, J. Mol. Cell. Cardiol. 46 (2009) 804–810.
[21] P.J. Cohen, Effect of anesthetics on mitochondrial function, Anesthesiology 39
(1973) 153–164.
[22] M.L. Nahrwold, P.J. Cohen, Anesthetics and mitochondrial respiration, Clin. Anesth.
11 (1975) 25–44.
[23] P.J. Hanley, J. Ray, U. Brandt, J. Daut, Halothane, isoﬂurane and sevoﬂurane inhibit
NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria, J. Physiol.
544 (2002) 687–693.
[24] F. Sedlic, D. Pravdic, N. Hirata, Y. Mio, A. Sepac, A.K. Camara, T. Wakatsuki, Z.J.
Bosnjak, M. Bienengraeber, Monitoring mitochondrial electron ﬂuxes using
NAD(P)H-ﬂavoprotein ﬂuorometry reveals complex action of isoﬂurane on
cardiomyocytes, Biochim. Biophys. Acta 1797 (2010) 1749–1758.
[25] D.F. Stowe, A.K. Camara, Mitochondrial reactive oxygen species production in excit-
able cells: modulators of mitochondrial and cell function, Antioxid. Redox Signal. 11
(2009) 1373–1414.
[26] M.M. Bradford, A rapid and sensitive method for the quantitation of microgram
quantities of protein utilizing the principle of protein–dye binding, Anal. Biochem.
72 (1976) 248–254.
[27] M. Aldakkak, D.F. Stowe, R.K. Dash, A.K. Camara, Mitochondrial handling of excess
Ca2+ is substrate-dependent with implications for reactive oxygen species genera-
tion, Free Radic. Biol. Med. 56 (2013) 193–203.
[28] A.D. Boelens, R.K. Pradhan, C.A. Blomeyer, A.K. Camara, R.K. Dash, D.F. Stowe,
Extra-matrix Mg(2+) limits Ca (2+) uptake and modulates Ca (2+) uptake-
independent respiration and redox state in cardiac isolatedmitochondria, J. Bioenerg.
Biomembr. 45 (2013) 203–218.
[29] C.A. Blomeyer, J.N. Bazil, D.F. Stowe, R.K. Pradhan, R.K. Dash, A.K. Camara, Dynamic
buffering of mitochondrial Ca(2+) during Ca (2+) uptake and Na (+)-induced
Ca (2+) release, J. Bioenerg. Biomembr. 45 (2013) 189–202.
[30] J. Haumann, R.K. Dash, D.F. Stowe, A.D. Boelens, D.A. Beard, A.K. Camara, Mitochon-
drial free [Ca2+] increases during ATP/ADP antiport and ADP phosphorylation:
exploration of mechanisms, Biophys. J. 99 (2010) 997–1006.
[31] R.C. Scaduto Jr., L.W. Grotyohann, Measurement of mitochondrial membrane poten-
tial using ﬂuorescent rhodamine derivatives, Biophys. J. 76 (1999) 469–477.
[32] A. Heinen, M. Aldakkak, D.F. Stowe, S.S. Rhodes, M.L. Riess, S.G. Varadarajan, A.K.
Camara, Reverse electron ﬂow-induced ROS production is attenuated by activation
of mitochondrial Ca2+-sensitive K + channels, Am. J. Physiol. Heart Circ. Physiol.
293 (2007) H1400–H1407.
[33] A. Heinen, A.K. Camara, M. Aldakkak, S.S. Rhodes, M.L. Riess, D.F. Stowe, Mitochon-
drial Ca2+-induced K + inﬂux increases respiration and enhances ROS production
while maintaining membrane potential, Am. J. Physiol. Cell Physiol. 292 (2007)
C148–C156.[34] S.M. Nadtochiy, L.S. Burwell, P.S. Brookes, Cardioprotection and mitochondrial
S-nitrosation: effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in
cardiac ischemia–reperfusion injury, J. Mol. Cell. Cardiol. 42 (2007) 812–825.
[35] E.J. Lesnefsky, Q. Chen, S. Moghaddas, M.O. Hassan, B. Tandler, C.L. Hoppel, Blockade
of electron transport during ischemia protects cardiac mitochondria, J. Biol. Chem.
279 (2004) 47961–47967.
[36] M. Shlafer, C.L. Myers, S. Adkins, Mitochondrial hydrogen peroxide generation and
activities of glutathione peroxidase and superoxide dismutase following global
ischemia, J. Mol. Cell. Cardiol. 19 (1987) 1195–1206.
[37] B. Lai, L. Zhang, L.Y. Dong, Y.H. Zhu, F.Y. Sun, P. Zheng, Inhibition of Qi site of mito-
chondrial complex III with antimycin A decreases persistent and transient sodium
currents via reactive oxygen species and protein kinase C in rat hippocampal CA1
cells, Exp. Neurol. 194 (2005) 484–494.
[38] X. Gao, X. Wen, L. Esser, B. Quinn, L. Yu, C.A. Yu, D. Xia, Structural basis for the qui-
none reduction in the bc1 complex: a comparative analysis of crystal structures of
mitochondrial cytochrome bc1 with bound substrate and inhibitors at the Qi site,
Biochemistry 42 (2003) 9067–9080.
[39] J.S. Armstrong, H. Yang, W. Duan, M. Whiteman, Cytochrome bc1 regulates the mi-
tochondrial permeability transition by two distinct pathways, J. Biol. Chem. 279
(2004) 50420–50428.
[40] A.J. Lambert, M.D. Brand, Superoxide production by NADH:ubiquinone oxidoreduc-
tase (complex I) depends on the pH gradient across the mitochondrial inner mem-
brane, Biochem. J. 382 (2004) 511–517.
[41] D. Pravdic, N. Hirata, L. Barber, F. Sedlic, Z.J. Bosnjak, M. Bienengraeber, Complex I
and ATP synthase mediate membrane depolarization and matrix acidiﬁcation by
isoﬂurane in mitochondria, Eur. J. Pharmacol. 690 (2012) 149–157.
[42] J.R. Treberg, C.L. Quinlan, M.D. Brand, Evidence for two sites of superoxide produc-
tion by mitochondrial NADH-ubiquinone oxidoreductase (complex I), J. Biol.
Chem. 286 (2011) 27103–27110.
[43] Y. Liu, G. Fiskum, D. Schubert, Generation of reactive oxygen species by the mito-
chondrial electron transport chain, J. Neurochem. 80 (2002) 780–787.
[44] S. Drose, L. Bleier, U. Brandt, A commonmechanism links differently acting complex
II inhibitors to cardioprotection: modulation of mitochondrial reactive oxygen spe-
cies production, Mol. Pharmacol. 79 (2011) 814–822.
[45] Q. Chen, S. Moghaddas, C.L. Hoppel, E.J. Lesnefsky, Ischemic defects in the electron
transport chain increase the production of reactive oxygen species from isolated
rat heart mitochondria, Am. J. Physiol. Cell Physiol. 294 (2008) C460–C466.
[46] S.M. Nadtochiy, A.J. Tompkins, P.S. Brookes, Different mechanisms of mitochondrial
proton leak in ischaemia/reperfusion injury and preconditioning: implications for
pathology and cardioprotection, Biochem. J. 395 (2006) 611–618.
[47] C. Steenbergen,M.E. Perlman, R.E. London, E. Murphy,Mechanism of preconditioning.
Ionic alterations, Circ. Res. 72 (1993) 112–125.
[48] A.K. Camara, E.J. Lesnefsky, D.F. Stowe, Potential therapeutic beneﬁts of strategies
directed to mitochondria, Antioxid. Redox Signal. 13 (2010) 279–347.
[49] M. Zaugg, E. Lucchinetti, M. Uecker, T. Pasch, M.C. Schaub, Anaesthetics and cardiac
preconditioning. Part I. Signalling and cytoprotective mechanisms, Br. J. Anaesth. 91
(2003) 551–565.
[50] M.L. Riess, J.T. Eells, L.G. Kevin, A.K. Camara, M.M. Henry, D.F. Stowe, Attenuation of
mitochondrial respiration by sevoﬂurane in isolated cardiac mitochondria is medi-
ated in part by reactive oxygen species, Anesthesiology 100 (2004) 498–505.
[51] G. Paradies, G. Petrosillo, M. Pistolese, F.M. Ruggiero, Reactive oxygen species affect
mitochondrial electron transport complex I activity through oxidative cardiolipin
damage, Gene 286 (2002) 135–141.
[52] L.B. Becker, New concepts in reactive oxygen species and cardiovascular reperfusion
physiology, Cardiovasc. Res. 61 (2004) 461–470.
[53] Q. Chen, E.J. Vazquez, S. Moghaddas, C.L. Hoppel, E.J. Lesnefsky, Production of reac-
tive oxygen species by mitochondria: central role of complex III, J. Biol. Chem. 278
(2003) 36027–36031.
[54] T.V. Votyakova, I.J. Reynolds, DeltaPsi(m)-dependent and -independent production
of reactive oxygen species by rat brain mitochondria, J. Neurochem. 79 (2001)
266–277.
[55] B.W. Palmisano, R.W.Mehner, D.F. Stowe, Z.J. Bosnjak, J.P. Kampine, Directmyocardial
effects of halothane and isoﬂurane. Comparison between adult and infant rabbits,
Anesthesiology 81 (1994) 718–729.
[56] V.G. Grivennikova, A.D. Vinogradov, Partitioning of superoxide and hydrogen perox-
ide production bymitochondrial respiratory complex I, Biochim. Biophys. Acta 1827
(2013) 446–454.
[57] N. Hirata, Y.H. Shim, D. Pravdic, N.L. Lohr, P.F. Pratt Jr., D. Weihrauch, J.R. Kersten,
D.C. Warltier, Z.J. Bosnjak, M. Bienengraeber, Isoﬂurane differentially modulates
mitochondrial reactive oxygen species production via forward versus reverse elec-
tron transport ﬂow: implications for preconditioning, Anesthesiology 115 (2011)
531–540.
